Business Context and Reporting Period
This Form 8-K was filed by MIND Technology, Inc. on July 27, 2022. The report addresses a regulatory notice received from the NASDAQ Stock Market LLC regarding the Company's compliance with listing standards.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on stock listing compliance rather than financial performance metrics.
Material Changes
The material event reported is the receipt of a written notice from NASDAQ stating that the Company's Common Stock has failed to maintain the minimum closing bid price of $1.00 per share for 30 consecutive business days, as required by Nasdaq Listing Rule 5550(a)(2). This deficiency does not have an immediate effect on the listing status of the Common Stock on the Nasdaq Capital Market.
Guidance, Outlook, and Risks
- Compliance Period: The Company has been granted an initial 180-calendar-day compliance period ending January 23, 2023, to regain compliance.
- Remediation Path: To regain compliance, the Common Stock must maintain a minimum closing bid price of at least $1.00 for a minimum of ten consecutive business days during the compliance period.
- Secondary Compliance: If the Company fails to comply by the initial deadline, it may be afforded a second 180-day period, provided it meets all other initial listing standards (excluding the bid price) and notifies NASDAQ of its intent to cure.
- Risk of Delisting: If the Company is unable to regain compliance during the available periods, NASDAQ anticipates issuing a notice that the Common Stock is subject to delisting.
- Management Action: The Company plans to assess potential actions to regain compliance but acknowledges the risk of being unable to do so.
Investor Verification Checklist
- Verify the current trading price of MIND Technology, Inc. (MIND) to assess proximity to the $1.00 threshold.
- Monitor the stock's closing bid price over the next 10 consecutive business days to determine if the Company can meet the immediate cure requirement.
- Review subsequent filings to confirm if the Company has notified NASDAQ of its intent to utilize a second compliance period if the first deadline is missed.
- Check for any reverse stock split announcements, which are a common method used by companies to address minimum bid price deficiencies.